Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015
Back to SEC Filings
Material AgreementItem 1.01 · 8-KLOW RiskPositive

SAGIMET BIOSCIENCES INC.

The company signed a major contract or deal. An 8-K is the notice a US public company must file within four business days of a major event.

3vbio.com
Filed: Sep 30, 2026San Mateo, CaliforniaCIK: 0001400118Biotechnology
View on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Sagimet Biosciences entered into an underwriting agreement on September 30, 2026, to conduct an underwritten public offering of 8.75 million shares of Series A common stock at $10.00 per share and 2.75 million pre-funded warrants at $9.9999 per share, raising approximately $87.5 million in gross proceeds to fund operational capabilities and strategic initiatives.

Key Takeaways

Sagimet is raising approximately $87.5 million through an underwritten offering of common stock and pre-funded warrants

The offering involves three underwriters: Leerink Partners LLC, TD Securities (USA) LLC, and Guggenheim Securities, LLC

2 more takeaways

Related Filings (1)

1 more filing from SAGIMET BIOSCIENCES INC. in the last 90 days

Filing Overview

Form Type8-K
Filing DateSep 30, 2026
Item1.01
CategoryMaterial Agreement
CIK0001400118
Accession #0001193125-26-409335
Risk LevelLOW
SentimentPositive
Signalopportunity
Topics
stock offeringmaterial agreement

What This Means

The company entered into a significant agreement that could materially affect its business. This often signals new partnerships, licensing deals, or major contracts.
View Full Filing on SEC.govBrowse More Filings

SAGIMET BIOSCIENCES INC. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

4 screens from a live account. No signup.